Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.

Immunology today - 1 Sept 1992

Bretscher P A

Abstract excerpt

The pathogens responsible for leprosy, tuberculosis and the leishmaniases can induce different classes of immunity, but protection is provided only by a cell-mediated response. Here, Peter Bretscher proposes a strategy to achieve an immunological imprint that ensures a stable cell-mediated response upon natural infection.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Vaccines
Share to Disease Susceptibility
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunity, Cellular

Share to Immunity, Innate

Share to Mice, Inbred BALB C

Share to Mycobacterium tuberculosis

Source

Identifiers

PMID: 1466750
DOI: 10.1016/0167-5699(92)90168-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.PMID 1466750Read ↗

BCG vaccine’s off-target effects on allergic, inflammatory, and autoimmune diseases: Worth another shot?Semantic proximity Read ↗

Defining the Kinetics, Phenotype, and Function of T Cells Induced by Mycobacterium tuberculosis: Pillar of Immunity to Tuberculosis.Semantic proximity Read ↗

Immunotherapeutics for Tuberculosis in Experimental Animals: Is There a Common Pathway Activated by Effective Protocols?Semantic proximity Read ↗

How can immunology contribute to the control of tuberculosis?Semantic proximity Read ↗

TB vaccines: current status and future perspectivesSemantic proximity Read ↗

Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memorySemantic proximity Read ↗

Tuberculosis vaccines — an updateSemantic proximity Read ↗

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-GuérinSemantic proximity Read ↗

Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in HumansSemantic proximity Read ↗

Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patientsSemantic proximity Read ↗

T-cell immune responses toBordetella pertussisinfection and vaccination: Graphical Abstract Figure.Semantic proximity Read ↗

A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and PrimatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.